BAK1 and prostate carcinoma: Clinical samples were found to overexpress miR-125b in prostate cancer, and enforced expression of miR-125b promoted tumor growth through mediation of broad attenuation of the intrinsic apoptosis pathway by targeting P53, PUMA, and BAK [17].